Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion type Assertion NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_head.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion description "[Mitochondrial encephalomyopathies are usually divided into three distinct clinical subgroups: (1) mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS); (2) myoclonus epilepsy associated with ragged-red fibres (MERRF); and (3) chronic progressive external ophthalmoplegia (CPEO) including Kearns-Sayre syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_provenance.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion evidence source_evidence_literature NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_provenance.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion SIO_000772 2102678 NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_provenance.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion wasDerivedFrom befree-20140225 NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_provenance.
- NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_assertion wasGeneratedBy ECO_0000203 NP319035.RAekUpXCQJQmnz2Qw4Ox0c8PpdtB9US68MAAN5Wveu4F8130_provenance.